Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid Tumors, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00060151
What this trial is testing

GW786034 in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center
Early research (Phase 1)Active Not RecruitingNCT05007782
What this trial is testing

Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Gilead Sciences 304
Early research (Phase 1)Study completedNCT00290680
What this trial is testing

Bortezomib and Celecoxib in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Medical University of South Carolina 36
Early research (Phase 1)Study completedNCT00567931
What this trial is testing

1-Methyl-D-Tryptophan in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 52
Early research (Phase 1)Ended earlyNCT05781360
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid Tumors

Who this might be right for
Locally Advanced Unresectable or Metastatic Solid Tumor
Jiangsu Simcere Pharmaceutical Co., Ltd. 192
Early research (Phase 1)Study completedNCT03873883
What this trial is testing

First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

Who this might be right for
Solid Tumor, Adult
iTeos Therapeutics 119
Testing effectiveness (Phase 2)Looking for participantsNCT04803318
What this trial is testing

Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultHepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 100
Early research (Phase 1)Study completedNCT00004189
What this trial is testing

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT05252390
What this trial is testing

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorOvarian CancerOvary Cancer+24 more
Nuvation Bio Inc. 82
Testing effectiveness (Phase 2)Looking for participantsNCT06656390
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK201 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced CancerAdvanced Solid Tumors
Shanghai Allink Biotherapeutics Co., Ltd. 202
Early research (Phase 1)Study completedNCT01154426
What this trial is testing

ABT-888 and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors

Who this might be right for
Adult Solid NeoplasmBRCA1 Mutation CarrierBRCA2 Mutation Carrier
National Cancer Institute (NCI) 31
Early research (Phase 1)Study completedNCT01030055
What this trial is testing

Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsCancerTumors
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Ended earlyNCT04471415
What this trial is testing

Study to Investigate DRP-104 in Adults With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNon Small Cell Lung Cancer Metastatic
Dracen Pharmaceuticals, Inc. 61
Early research (Phase 1)Study completedNCT05114668
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid Tumours

Who this might be right for
Solid Tumor, Adult
Kazia Therapeutics Limited 32
Early research (Phase 1)Ended earlyNCT00807755
What this trial is testing

Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors

Who this might be right for
Lung CancerUnspecified Adult Solid Tumor, Protocol Specific
University of California, Davis 5
Early research (Phase 1)Study completedNCT04293094
What this trial is testing

Study of AMG 650 in Adult Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Volastra Therapeutics, Inc. 66
Early research (Phase 1)Study completedNCT00047242
What this trial is testing

UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30
Early research (Phase 1)Ended earlyNCT01147029
What this trial is testing

GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Cancer Research UK 35
Early research (Phase 1)Study completedNCT00004220
What this trial is testing

Oxaliplatin and Gemcitabine in Treating Patients With Advanced Cancer

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06265025
What this trial is testing

GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerMalignant MelanomaColorectal Cancer+3 more
GeneMedicine Co., Ltd. 125
Next Page